From diabetes care to migraine relief-GLP-1 therapy cuts monthly headache days and boosts daily function in chronic migraine patients with obesity.

During an appearance on the Just Trish podcast, Lizzo admitted to using Ozempic and other GLP-1 medication at a certain point in her weight loss...

MONDAY, June 30, 2025 -- For adults with obesity and migraine, liraglutide reduces migraine burden, with reductions in mean monthly headache days and...

A new combination therapy has shown improved results for patients with bKRAS G12C metastatic colorectal cancer /bwho no longer respond to...

Tirzepatide and GLP-1 receptor agonists are replacing older treatments, marking a shift in how diabetes and weight loss are managed.

Metformin shows promise in reducing knee osteoarthritis pain in overweight individuals and delaying surgery.

Women demonstrate significantly bhigher awareness and understanding of medlinkobesity drugs/medlink,/b including GLP-1/GIP receptor agonists such

Women demonstrate significantly bhigher awareness and understanding of medlinkobesity drugs/medlink,/b including GLP-1/GIP receptor agonists such

A diabetes medication that lowers brain fluid pressure has cut monthly migraine days by more than half, according to a new study presented today at...

A diabetes medication that lowers brain fluid pressure has cut monthly migraine days by more than half, according to a new study presented today at...